Agile Therapeutics, Inc.

Agile Therapeutics, Inc.verified

AGRX

Price:

$1.51

Market Cap:

$10.43M

Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line extensions and other products, including AG200-15 Extended Regimen (ER), a regimen that allows a woman to have four episodes of withdrawal bleeding per year; AG200-15 smaller patch (SmP), which is a regimen designed to provide shorter and lighter withdrawal bleeds, and enhance contraceptive efficacy; AG200-15 ER SmP, a regimen to allow a woman to extend t...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2014-05-23

Stock Exchange

NASDAQ

Ticker

AGRX

The Current Ratio as of November 2024 (TTM) for Agile Therapeutics, Inc. (AGRX) is 0.55

According to Agile Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.55. This represents a change of 2.82% compared to the average of 0.54 of the last 4 quarters.

Agile Therapeutics, Inc. (AGRX) Historical Current Ratio (quarterly & annually)

How has AGRX Current Ratio performed in the past?

The mean historical Current Ratio of Agile Therapeutics, Inc. over the last ten years is 3.97. The current 0.55 Current Ratio has changed 1.29% with respect to the historical average. Over the past ten years (40 quarters), AGRX's Current Ratio was at its highest in in the March 2020 quarter at 33.69. The Current Ratio was at its lowest in in the December 2023 quarter at 0.46.

Quarterly (TTM)
Annual

Average

3.97

Median

4.19

Minimum

0.46

Maximum

9.31

Agile Therapeutics, Inc. (AGRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Agile Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.28%

Maximum Annual Current Ratio = 9.31

Minimum Annual Increase = -89.42%

Minimum Annual Current Ratio = 0.46

Quarterly (TTM)
Annual
YearCurrent RatioChange
20230.46-45.94%
20220.853.83%
20210.82-89.42%
20207.72-17.02%
20199.31144.06%
20183.8148.24%
20172.57-46.68%
20164.820.51%
20154.805.31%
20144.561.28%

Agile Therapeutics, Inc. (AGRX) Average Current Ratio

How has AGRX Current Ratio performed in the past?

The current Current Ratio of Agile Therapeutics, Inc. (AGRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0.71

5-year avg

3.83

10-year avg

3.97

Agile Therapeutics, Inc. (AGRX) Current Ratio vs. Peers

How is AGRX’s Current Ratio compared to its peers?

Agile Therapeutics, Inc.’s Current Ratio is less than Assertio Holdings, Inc. (2.01), less than Amneal Pharmaceuticals, Inc. (1.38), less than AcelRx Pharmaceuticals, Inc. (4.04), less than Lifecore Biomedical, Inc. (1.83), less than Guardion Health Sciences, Inc. (16.67), less than Alpha Teknova, Inc. (4.73), greater than Cyclo Therapeutics, Inc. (0.17), less than Petros Pharmaceuticals, Inc. (0.85), greater than Shuttle Pharmaceuticals Holdings, Inc. (0.22), less than Mallinckrodt plc (2.74), less than Athenex, Inc. (1.09), less than Evoke Pharma, Inc. (1.44), less than Cumberland Pharmaceuticals Inc. (1.13), less than PainReform Ltd. (0.61), less than Aquestive Therapeutics, Inc. (6.37),

Build a custom stock screener for Agile Therapeutics, Inc. (AGRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Agile Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Agile Therapeutics, Inc. (AGRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Agile Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Agile Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Agile Therapeutics, Inc. (AGRX)?

What is the highest Current Ratio for Agile Therapeutics, Inc. (AGRX)?

What is the 3-year average Current Ratio for Agile Therapeutics, Inc. (AGRX)?

What is the 5-year average Current Ratio for Agile Therapeutics, Inc. (AGRX)?

How does the current Current Ratio for Agile Therapeutics, Inc. (AGRX) compare to its historical average?